Sarclisa (isatuximab-irfc) for the Treatment of Multiple Myeloma

Sarclisa® (isatuximab-irfc) is indicated for the treatment of multiple myeloma. Credit: Sanofi-Aventis.



  • Sarclisa
  • Sarclisa
  • Sarclisa
  • Sarclisa